UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 769

Sortiert nach

Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan

Journal of viral hepatitis, 2018-08, Vol.25 (8), p.945-951

2018

Volltextzugriff (PDF)

Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan

Journal of viral hepatitis, 2018-11, Vol.25 (11), p.1312-1320

2018

Volltextzugriff (PDF)

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

Hepatology (Baltimore, Md.), 2005-10, Vol.42 (4), p.962-973

2005

Volltextzugriff (PDF)

Natural history of bleeding risk in colonic diverticulosis patients: a long‐term colonoscopy‐based cohort study

Alimentary pharmacology & therapeutics, 2015-05, Vol.41 (9), p.888-894

2015

Volltextzugriff (PDF)

Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct‐acting antiviral therapy

Journal of viral hepatitis, 2018-05, Vol.25 (5), p.608-611

2018

Volltextzugriff (PDF)

Toll-Like Receptor 4 Pathway Mediate Liver Fibrosis in Chimeric Mice with Human Hepatocytes Persistently Infected with HBV

Journal of hepatology, 2016, Vol.64 (2), p.S392-S392

2016

Volltextzugriff (PDF)

Resistance Analyses of Japanese Hepatitis C-Infected Patients Receiving Sofosbuvir or Ledipasvir/Sofosbuvir Containing Regimens in Phase 3 Studies

Journal of viral hepatitis, 2016-10, Vol.23 (10), p.780-788

2016

Volltextzugriff (PDF)

Vegetable, fruit and antioxidant nutrient consumption and subsequent risk of hepatocellular carcinoma: a prospective cohort study in Japan

British journal of cancer, 2009-01, Vol.100 (1), p.181-184

2009

Volltextzugriff (PDF)

Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels

Gut, 2008-01, Vol.57 (1), p.98-102

2008

Volltextzugriff (PDF)

Utility of Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) for Advanced Fibrosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease

Journal of hepatology, 2016, Vol.64 (2), p.S732-S733

2016

Volltextzugriff (PDF)

Phylogenetic and phylodynamic analyses of hepatitis C virus subtype 1a in Okinawa, Japan

Journal of viral hepatitis, 2018-08, Vol.25 (8), p.976-985

2018

Volltextzugriff (PDF)

Serum Wisteria Floribunda agglutinin-positive sialylated mucin 1 as a biomarker of hepatic progenitor cell/biliary features in hepatocellular carcinoma and of recurrence after curative therapy

Journal of hepatology, 2017, Vol.66 (1), p.S617-S617

2017

Volltextzugriff (PDF)

Activated Fibroblasts Recovered from the Cirrhotic Liver Provide Malignancy-Prone Phenotypes to Cancer Cells and Macrophages: Comparable Capacity with Cancer-Associated Fibroblasts in Hepatocellular Carcinoma

Journal of hepatology, 2016, Vol.64 (2), p.S155-S156

2016

Volltextzugriff (PDF)

FATIGUE IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH LEDIPASVIR AND SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN

Value in health, 2016-05, Vol.19 (3), p.A316-A317

2016

Volltextzugriff (PDF)

HEALTH UTILITY ASSESSMENT IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS TREATED WITH INTERFERON-FREE REGIMENS

Value in health, 2016-05, Vol.19 (3), p.A316-A316

2016

Volltextzugriff (PDF)

P760 HIGH-THROUGHPUT AND ULTRASENSITIVE NEXT-GENERATION PCR ASSAY FOR THE QUANTIFICATION OF THE HEPATITIS C VIRUS MUTATION AT CORE AMINO ACID 70

Journal of hepatology, 2014-04, Vol.60 (1), p.S324-S324

2014

Volltextzugriff (PDF)

Sustained virologic response by ledipasvir/sofosbuvir reduces the incidence of hepatocellular carcinoma in Japanese patients with HCV genotype 1 infection. - Comparison with Simeprevir with peginterferon plus ribavirin

Journal of hepatology, 2017, Vol.66 (1), p.S23-S23

2017

Volltextzugriff (PDF)

Serum Levels of Wisteria Floribunda Agglutinin-Positive MAC-2 Binding Protein as Short-Term Predictors of Hepatocellular Carcinoma in Chronic Hepatitis B

Journal of hepatology, 2016, Vol.64 (2), p.S363-S364

2016

Volltextzugriff (PDF)

Elevated serum wisteria floribunda agglutinin-positive mac-2-binding protein levels associated with risks of diabetes and endstage renal diseases among patients with hepatitis C virus infection

Journal of hepatology, 2017, Vol.66 (1), p.S713-S714

2017

Volltextzugriff (PDF)

A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness

Journal of general virology, 2001-04, Vol.82 (4), p.883-892

2001

Volltextzugriff (PDF)

Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization

Archives of virology, 1998-01, Vol.143 (12), p.2493-2503

1998

Volltextzugriff (PDF)

Identification of a Protein Fragment of Interleukin 2 Responsible for Vasopermeability

JNCI : Journal of the National Cancer Institute, 2003-05, Vol.95 (10), p.741-749

2003

Volltextzugriff (PDF)

New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a

Journal of Clinical Microbiology, 1997-01, Vol.35 (1), p.201-207

1997

Volltextzugriff (PDF)

P0773 : The prevalence and the effect of HCV NS5A resistance associated variants in subjects with compensated cirrhosis treated with ledipasvir/sofosbuvir +/- RBV

Journal of hepatology, 2015-04, Vol.62, p.S620-S620

2015

Volltextzugriff (PDF)

Two Subtypes of Genotype B (Ba and Bj) of Hepatitis B Virus in Japan

Clinical infectious diseases, 2004-05, Vol.38 (9), p.1222-1228

2004

Volltextzugriff (PDF)

1 – 25 von 769

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(682)
Mit Volltextzugriff
(637)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan

Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

Natural history of bleeding risk in colonic diverticulosis patients: a long‐term colonoscopy‐based cohort study

Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct‐acting antiviral therapy

Toll-Like Receptor 4 Pathway Mediate Liver Fibrosis in Chimeric Mice with Human Hepatocytes Persistently Infected with HBV

Resistance Analyses of Japanese Hepatitis C-Infected Patients Receiving Sofosbuvir or Ledipasvir/Sofosbuvir Containing Regimens in Phase 3 Studies

Vegetable, fruit and antioxidant nutrient consumption and subsequent risk of hepatocellular carcinoma: a prospective cohort study in Japan

Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels

Utility of Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) for Advanced Fibrosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease

Phylogenetic and phylodynamic analyses of hepatitis C virus subtype 1a in Okinawa, Japan

Serum Wisteria Floribunda agglutinin-positive sialylated mucin 1 as a biomarker of hepatic progenitor cell/biliary features in hepatocellular carcinoma and of recurrence after curative therapy

Activated Fibroblasts Recovered from the Cirrhotic Liver Provide Malignancy-Prone Phenotypes to Cancer Cells and Macrophages: Comparable Capacity with Cancer-Associated Fibroblasts in Hepatocellular Carcinoma

FATIGUE IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH LEDIPASVIR AND SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN

HEALTH UTILITY ASSESSMENT IN JAPANESE PATIENTS WITH CHRONIC HEPATITIS TREATED WITH INTERFERON-FREE REGIMENS

P760 HIGH-THROUGHPUT AND ULTRASENSITIVE NEXT-GENERATION PCR ASSAY FOR THE QUANTIFICATION OF THE HEPATITIS C VIRUS MUTATION AT CORE AMINO ACID 70

Sustained virologic response by ledipasvir/sofosbuvir reduces the incidence of hepatocellular carcinoma in Japanese patients with HCV genotype 1 infection. - Comparison with Simeprevir with peginterferon plus ribavirin

Serum Levels of Wisteria Floribunda Agglutinin-Positive MAC-2 Binding Protein as Short-Term Predictors of Hepatocellular Carcinoma in Chronic Hepatitis B

Elevated serum wisteria floribunda agglutinin-positive mac-2-binding protein levels associated with risks of diabetes and endstage renal diseases among patients with hepatitis C virus infection

A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness

Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization

Identification of a Protein Fragment of Interleukin 2 Responsible for Vasopermeability

New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a

P0773 : The prevalence and the effect of HCV NS5A resistance associated variants in subjects with compensated cirrhosis treated with ledipasvir/sofosbuvir +/- RBV

Two Subtypes of Genotype B (Ba and Bj) of Hepatitis B Virus in Japan

Suchergebnisse filtern